<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34945095</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>24</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5799</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm10245799</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) is a multisystem illness caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which can manifest with a multitude of symptoms in the setting of end-organ damage, though it is predominantly respiratory. However, various symptoms may remain after acute SARS-CoV-2 infection, and this condition is referred to as "Long COVID" (LC). Patients with LC may develop multi-organ symptom complex that remains 4-12 weeks after the acute phase of illness, with symptoms intermittently persisting over time. The main symptoms are fatigue, post-exertional malaise, cognitive dysfunction, and limitation of functional capacity. Pediatric patients developed the main symptoms of LC like those described in adults, although there may be variable presentations of LC in children. The underlying mechanisms of LC are not clearly known, although they may involve pathophysiological changes generated by virus persistence, immunological alterations secondary to virus-host interaction, tissue damage of inflammatory origin and hyperactivation of coagulation. Risk factors for developing LC would be female sex, more than five early symptoms, early dyspnea, previous psychiatric disorders, and alterations in immunological, inflammatory and coagulation parameters. There is currently no specific treatment for LC, but it could include pharmacological treatments to treat symptoms, supplements to restore nutritional, metabolic, and gut flora balance, and functional treatments for the most disabling symptoms. In summary, this study aims to show the scientific community the current knowledge of LC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-L&#xe1;zaro</LastName><ForeName>Diego</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6522-8896</Identifier><AffiliationInfo><Affiliation>Department of Cellular Biology, Histology and Pharmacology, Faculty of Health Sciences, University of Valladolid, Campus of Soria, 42003 Soria, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurobiology Research Group, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Serrano</LastName><ForeName>Nerea</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Microbiology Unit of the Santa B&#xe1;rbara Hospital, Castille and Leon Health (SACyL), 42003 Soria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mielgo-Ayuso</LastName><ForeName>Juan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6554-4602</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, Faculty of Health Sciences, University of Burgos, 09001 Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Hern&#xe1;ndez</LastName><ForeName>Juan Luis</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-2146-5726</Identifier><AffiliationInfo><Affiliation>Molecular Mechanisms of Cancer Program, Institute of Molecular and Cellular Biology of Cancer, Spanish National Research Council (CSIC), University of Salamanca, 37007 Salamanca, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hematology, Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, 37007 Salamanca, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Bernal</LastName><ForeName>Jer&#xf3;nimo J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-7298-9060</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences, Faculty of Health Sciences, University of Burgos, 09001 Burgos, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seco-Calvo</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7818-9777</Identifier><AffiliationInfo><Affiliation>Physiotherapy Department, Institute of Biomedicine (IBIOMED), University of Leon, Campus de Vegazana, 24071 Leon, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Basque Country University, 48930 Leioa, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>07.04.467804.74011.0</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>&#xb0; 07.04.467804.74011.0</GrantID><Agency>Consejer&#xed;a de Educaci&#xf3;n Junta of Castilla-Leon</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pathways</Keyword><Keyword MajorTopicYN="N">symptomatology</Keyword><Keyword MajorTopicYN="N">therapy</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34945095</ArticleId><ArticleId IdType="pmc">PMC8708091</ArticleId><ArticleId IdType="doi">10.3390/jcm10245799</ArticleId><ArticleId IdType="pii">jcm10245799</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105924</ArticleId><ArticleId IdType="pmc">PMC7127800</ArticleId><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabish S.A. COVID-19 pandemic: Emerging perspectives and future trends. J. Public Health Res. 2020;9:19&#x2013;26. doi: 10.4081/jphr.2020.1786.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/jphr.2020.1786</ArticleId><ArticleId IdType="pmc">PMC7282311</ArticleId><ArticleId IdType="pubmed">32550223</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Map&#x2014;Johns Hopkins Coronavirus Resource Center.  [(accessed on 18 August 2021)].  Available online:  https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D., Fernandez-Lazaro C.I., Mielgo-Ayuso J., Adams D.P., Garc&#xed;a Hern&#xe1;ndez J.L., Gonz&#xe1;lez-Bernal J., Gonz&#xe1;lez-Gross M. Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2. Front. Immunol. 2021;12:1&#x2013;13. doi: 10.3389/fimmu.2021.698672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.698672</ArticleId><ArticleId IdType="pmc">PMC8248499</ArticleId><ArticleId IdType="pubmed">34220861</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D., G&#xf3;mez N.S., Serrano N.S., Sosse A.A., Aldea-Mansilla C. Emergency Standardization for SARS-CoV-2 Virus Diagnosis by Real-Time Reverse Transcription-Reverse Polymerase Chain Reaction (RT-PCR) in a COVID-19 Pandemic Situation. Rev. Madrile&#xf1;a Salud P&#xfa;blica. 2020;4:1&#x2013;11. doi: 10.36300/remasp.2020.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.36300/remasp.2020.070</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Ko W.C., Lee P.I., Jean S.S., Hsueh P.R. Extra-respiratory manifestations of COVID-19. Int. J. Antimicrob. Agents. 2020;56:106024. doi: 10.1016/j.ijantimicag.2020.106024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106024</ArticleId><ArticleId IdType="pmc">PMC7243791</ArticleId><ArticleId IdType="pubmed">32450197</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long Covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of post-acute Covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  What We Know about Long-Term Effects of COVID-19. 2020.  [(accessed on 24 August 2021)].  Available online:  https://scholar.google.es/scholar?hl=es&amp;as_sdt=0%2C5&amp;q=What+we+know+about+long-term+effects+of+COVID-19.+The+latest+on+the+COVID-19+global+situation+and+long-term+sequelae&amp;btnG=</Citation></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications. JAMA. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>The National Institute for Health and Care Excellence (NICE) COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. The National Institute for Health and Care Excellence (NICE); London, UK: 2021. pp. 1&#x2013;111. NICE Guideline [NG188]</Citation></Reference><Reference><Citation>Ministry of Health, Government of Spain, Health Alerts and Emergencies Coordination Center  Contributions of This Update Scientific-Technical Information Coronavirus Disease, COVID-19.  [(accessed on 24 August 2021)];2021 :1&#x2013;111. Available online:  https://www.aemps.gob.es/https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/vacunasCovid19.htm.</Citation></Reference><Reference><Citation>World Health Organization (WHO)  What Is Health Policy and Systems Research. 2021.  [(accessed on 24 August 2021)].  Available online:  https://ahpsr.who.int/what-we-do/what-is-health-policy-and-systems-research-(hpsr)</Citation></Reference><Reference><Citation>Andrade B.S., Siqueira S., Soares W.R.d.A., Rangel F.d.S., Santos N.O., Freitas A.d.S., Silveira P.R.d., Tiwari S., Alzahrani K.J., G&#xf3;es-Neto A., et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021;13:700. doi: 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Ledo P., Armenteros del Olmo L., Guerrero Caballero S., Bilbao Fern&#xe1;ndez S. The persistence of COVID-19 symptoms and its diagnosis in the first wave of the pandemic in Spain. Med. Gen. Y Fam. 2021;10:53&#x2013;59. doi: 10.24038/mgyf.2021.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.24038/mgyf.2021.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Adil S.F., Alkhathlan H.Z., Tahir M.N., Saif S., Khan M., Khan S.T. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules. 2020;26:39. doi: 10.3390/molecules26010039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26010039</ArticleId><ArticleId IdType="pmc">PMC7795815</ArticleId><ArticleId IdType="pubmed">33374759</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  International Classification of Diseases, 11th Revision (IDC-11) 2020.  [(accessed on 26 August 2021)].  Available online:  https://icd.who.int/es.</Citation></Reference><Reference><Citation>L&#xb4;Assurance Maladie (ameli.fr)  Sympt&#xf4;mes Prolong&#xe9;s Suite &#xe0; la Covid-19: Diagnostic et Prise en Charge. M&#xe9;decin. 2021.  [(accessed on 28 August 2021)].  Available online:  https://www.ameli.fr/medecin/actualites/symptomes-prolonges-suite-la-covid-19-diagnostic-et-prise-en-charge.</Citation></Reference><Reference><Citation>Chippa V., Aleem A., Anjum F.  StatPearls Publishing; Treasure Island, FL, USA: 2021.  [(accessed on 26 August 2021)]. Post-Acute Coronavirus (COVID-19) Syndrome. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK570608/</Citation><ArticleIdList><ArticleId IdType="pubmed">34033370</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Guevara-Coto J., Yogendra R., Francisco E.B., Long E., Pise A., Rodrigues H., Parikh P., Mora J., Mora-Rodr&#xed;guez R.A. l Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. Front. Immunol. 2021;12:700782. doi: 10.3389/fimmu.2021.700782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Frauke Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira D.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S.W.X., Fong S.W., Young B.E., Chan Y.H., Lee B., Amrun S.N., Chee R.S.-L., Yeo N.K.-W., Tambyah P., Pada S., et al. Persistent Symptoms and Association with Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum Infect. Dis. 2021;8:ofab156. doi: 10.1093/ofid/ofab156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez Reyes A., Villegas Valverde C.A., Su&#xe1;rez Reyes A., Villegas Valverde C.A. Characteristics and specialization of the immune response in COVID-19. Rev. Fac. Med. 2020;63:7&#x2013;18.</Citation></Reference><Reference><Citation>Bergamaschi L., Mescia F., Turner L., Hanson A., Kotagiri P., Dunmore B.J., Ruffieux H., De Sa A., Oisin Huhn O., Wills M.R., et al. Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19. medRxiv. 2021;1:01J. doi: 10.2139/ssrn.3757074.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3757074</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Estes S.K., Ali R.A., Gandhi A.A., Yalavarthi S., Shi H., Sule G., Gockman K., Madison J.A., Zuo M., et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. 2020;12:eabd3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Liu F., Zheng N.S., Zhou T., Israelow B., Wong P., et al. Diverse Functional Autoantibodies in Patients with COVID-19. medRxiv Prepr. Serv. Heal Sci. 2021:preprint. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Wang B., Mu K., Zhang J.A. The pathogenesis of thyroid autoimmune diseases: New T lymphocytes&#x2014;Cytokines circuits beyond the Th1-Th2 paradigm. J Cell Physiol. 2019;234:2204&#x2013;2216. doi: 10.1002/jcp.27180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27180</ArticleId><ArticleId IdType="pubmed">30246383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu D.T.W., Lee C.H., Chow W.S., Lee A.C.H., Tam A.R., Fong C.H.Y., Law C.Y., Hong Leung E.K., Wang To K.K., Beng Tan K.C., et al. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. J. Clin. Endocrinol. Metab. 2021;106:e926&#x2013;e935. doi: 10.1210/clinem/dgaa813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa813</ArticleId><ArticleId IdType="pmc">PMC7665541</ArticleId><ArticleId IdType="pubmed">33141191</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalli J. Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections? Mol. Asp. Med. 2017;58:12&#x2013;20. doi: 10.1016/j.mam.2017.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2017.03.007</ArticleId><ArticleId IdType="pubmed">28365269</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N. Treating inflammation and infection in the 21st century: New hints from decoding resolution mediators and mechanisms. FASEB J. 2017;31:1273&#x2013;1288. doi: 10.1096/fj.201601222R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201601222R</ArticleId><ArticleId IdType="pmc">PMC5349794</ArticleId><ArticleId IdType="pubmed">28087575</ArticleId></ArticleIdList></Reference><Reference><Citation>Regidor P.A., Santos F.G., Rizo J.M., Egea F.M. Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19. Med. Hypotheses. 2020;145:110340. doi: 10.1016/j.mehy.2020.110340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110340</ArticleId><ArticleId IdType="pmc">PMC7543931</ArticleId><ArticleId IdType="pubmed">33069094</ArticleId></ArticleIdList></Reference><Reference><Citation>Regidor P.A. Covid-19 management with inflammation resolving mediators? Perspectives and potential. Med. Hypotheses. 2020;142:109813. doi: 10.1016/j.mehy.2020.109813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109813</ArticleId><ArticleId IdType="pmc">PMC7204710</ArticleId><ArticleId IdType="pubmed">32416413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R., Rathi H., Haq A., Wimalawansa S.J., Sharma A. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res. 2021;292:198235. doi: 10.1016/j.virusres.2020.198235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198235</ArticleId><ArticleId IdType="pmc">PMC7680047</ArticleId><ArticleId IdType="pubmed">33232783</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogero M.M., de Le&#xe3;o M.C., Santana T.M., de Pimentel M.V.M.B., Carlini G.C.G., Silveira T.F.F., Gon&#xe7;alves R.C., Castro I.A. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic. Biol. Med. 2020;156:190&#x2013;199. doi: 10.1016/j.freeradbiomed.2020.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.07.005</ArticleId><ArticleId IdType="pmc">PMC7350587</ArticleId><ArticleId IdType="pubmed">32653511</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente-Su&#xe1;rez V.J., Ramos-Campo D.J., Mielgo-Ayuso J., Dalamitros A.A., Nikolaidis P.A., Horme&#xf1;o-Holgado A., Tornero-Aguilera J.F. Nutrition in the Actual COVID-19 Pandemic. A Narrative Review. Nutrients. 2021;13:1924. doi: 10.3390/nu13061924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13061924</ArticleId><ArticleId IdType="pmc">PMC8228835</ArticleId><ArticleId IdType="pubmed">34205138</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakoor H., Feehan J., Dhaheri A.S., Al Ali H.I., Platat C., Ismail L.C., Apostolopoulos V., Stojanovska L. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas. 2021;143:1&#x2013;9. doi: 10.1016/j.maturitas.2020.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2020.08.003</ArticleId><ArticleId IdType="pmc">PMC7415215</ArticleId><ArticleId IdType="pubmed">33308613</ArticleId></ArticleIdList></Reference><Reference><Citation>Maraver-Romero R. Could the Mediterranean lifestyle prevent complications from Covid-19 infection? Actual. Med. 2020;105:66&#x2013;68. doi: 10.15568/am.2020.809.adm01.</Citation><ArticleIdList><ArticleId IdType="doi">10.15568/am.2020.809.adm01</ArticleId></ArticleIdList></Reference><Reference><Citation>Haig D.M.K., McInnes C., Deane D., Reid H., Mercer A. The immune and inflammatory response to orf virus. Comp. Immunol. Microbiol. Infect. Dis. 1997;20:197&#x2013;204. doi: 10.1016/S0147-9571(96)00045-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0147-9571(96)00045-8</ArticleId><ArticleId IdType="pubmed">9280386</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L., Rao X., Sigdel K.R. Regulation of inflammation in autoimmune disease. J. Immunol. Res. 2019;1:7403796. doi: 10.1155/2019/7403796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7403796</ArticleId><ArticleId IdType="pmc">PMC6421792</ArticleId><ArticleId IdType="pubmed">30944837</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Gelardi F., Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: An [18F]FDG-PET/CT study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:1460&#x2013;1466. doi: 10.1007/s00259-020-05084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi H.K., Mehra M.R. COVID-19 illness in native and immunosuppressed states: A clinical&#x2013;therapeutic staging proposal. J. Heart Lung Transpl. 2020;39:405&#x2013;407. doi: 10.1016/j.healun.2020.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2020.03.012</ArticleId><ArticleId IdType="pmc">PMC7118652</ArticleId><ArticleId IdType="pubmed">32362390</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Han J., Cheng X., Yu L., Zhang L., Wang W., Ni L., Wei C., Yafei Huang Y., Cheng Z. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients. Sci. Rep. 2020;10:17718. doi: 10.1038/s41598-020-73955-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73955-8</ArticleId><ArticleId IdType="pmc">PMC7573596</ArticleId><ArticleId IdType="pubmed">33077873</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cells. 2014;157:121&#x2013;141. doi: 10.1016/j.cell.2014.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.03.011</ArticleId><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhan H., Zhan F., Liu Q., Tso E.Y., Lui G.C., Chen N., Li A., Lu W., Chan F.K.L., et al. Alterations in Fecal Fungal Microbiome of Patients with COVID-19 during Time of Hospitalization until Discharge. Gastroenterology. 2020;159:1302&#x2013;1310. doi: 10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Marazzato M., Ceccarelli G., d&#x2019;Ettorre G. Dysbiosis in SARS-CoV-2&#x2013;Infected Patients. Gastroenterology. 2021;160:2195. doi: 10.1053/j.gastro.2020.12.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.12.056</ArticleId><ArticleId IdType="pmc">PMC7773314</ArticleId><ArticleId IdType="pubmed">33387514</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero Caballero S., Bilbao Fern&#xe1;ndez S. Persistence of SARS-CoV-2 virus as an etiologic cause of long-lasting symptomatology in patients with persistent COVID-19. Med. Gen. Y Fam. 2021;10:85&#x2013;90. doi: 10.24038/mgyf.2021.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.24038/mgyf.2021.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., Yin H., Xiao Q., Tang Y., Qu X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 2020;5:434&#x2013;435. doi: 10.1016/S2468-1253(20)30083-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020;158:1831&#x2013;1833. doi: 10.1053/j.gastro.2020.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone C., Bizkarguenaga M., Gil-Redondo R., Diercks T., Arana E., Garc&#xed;a de Vicu&#xf1;a A., Seco M., Bosch A., Palaz&#xf3;n A., San Juan I., et al. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum. iScience. 2020;23:101645. doi: 10.1016/j.isci.2020.101645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101645</ArticleId><ArticleId IdType="pmc">PMC7534591</ArticleId><ArticleId IdType="pubmed">33043283</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.G., Fralick M., Sholzberg M. Coagulopathy associated with COVID-19. CMAJ. 2020;192:e583. doi: 10.1503/cmaj.200685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.200685</ArticleId><ArticleId IdType="pmc">PMC7259970</ArticleId><ArticleId IdType="pubmed">32357997</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. COVID-19 update: Covid-19-associated coagulopathy. J. Thromb. Thrombolysis. 2020;50:54&#x2013;67. doi: 10.1007/s11239-020-02134-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02134-3</ArticleId><ArticleId IdType="pmc">PMC7225095</ArticleId><ArticleId IdType="pubmed">32415579</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V., Sohaei D., Diamandis E.P., Prassas I. COVID-19: From an acute to chronic disease? Potential long-term health consequences. Crit. Rev. Clin. Lab. Sci. 2021;58:297&#x2013;310. doi: 10.1080/10408363.2020.1860895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  The Prevalence of Long COVID Symptoms and COVID-19 Complications.  [(accessed on 29 August 2021)];2020  Available online:  https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications.</Citation></Reference><Reference><Citation>Office for National Statistics  Updated Estimates of the Prevalence of Prolonged COVID-19 Symptoms.  [(accessed on 29 August 2021)];2021  Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/adhocs/12788updatedestimatesoftheprevalenceoflongcovidsymptoms.</Citation></Reference><Reference><Citation>Cirulli E.T., Barrett K.M.S., Riffle S., Bolze A., Neveux I., Dabe S., Grzymski J.J., Lu J.T., Washington N.L. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020 preprint.</Citation></Reference><Reference><Citation>Rajan S., Khunti K., Alwan N., Steves C., MacDermott N., Morsella A., Angulo E., Winkelmann J., Bryndov&#xe1; L., Fronteira  I., et al.   The Wake of the Pandemic: Preparing for Long COVID. European Observatory on Health Systems and Policies; Copenhagen, Denmark: 2021.  [(accessed on 29 August 2021)].  Available online:  http://europepmc.org/books/NBK569598.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health Government of Spain  Clinical Information COVID-19.  [(accessed on 29 August 2021)];2021 :1&#x2013;34. Available online:  https://www.mscbs.gob.es/en/profesionales/saludPublica/</Citation></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Signe Redfield S., Austin J.-P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Ledo P., Armenteros del Olmo L., Rodr&#xed;guez Rodr&#xed;guez E., G&#xf3;mez Acebo F. Description of the 201 symptoms of multiorgan involvement in patients affected by persistent COVID-19. Med. Gen. Y Fam. 2021;10:60&#x2013;68. doi: 10.24038/mgyf.2021.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.24038/mgyf.2021.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D., Garrosa M. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. Viruses. 2021;13:1916. doi: 10.3390/v13101916.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13101916</ArticleId><ArticleId IdType="pmc">PMC8540564</ArticleId><ArticleId IdType="pubmed">34696346</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins M.M., Prata-Barbosa A., Ledo Alves da Cunha A.J. Update on SARS-CoV-2 infection in children. Paediatr. Int. Child Health. 2021;41:56&#x2013;64. doi: 10.1080/20469047.2021.1888026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20469047.2021.1888026</ArticleId><ArticleId IdType="pubmed">33616026</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira L&#xf3;pez J., Grasa C., Calvo C., Garc&#xed;a L&#xf3;pez-Hortelano M. Long-term symptoms of COVID-19 in children. Acta Paediatr. 2021;110:2282&#x2013;2283. doi: 10.1111/apa.15849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15849</ArticleId><ArticleId IdType="pmc">PMC8251185</ArticleId><ArticleId IdType="pubmed">33745209</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel C.L., Lap C.R., Buddingh E.P., van Houten M.A., van der Sande L.J., Langereis E.J., Bannier M.A.G.E., Pijnenburg M.W.H., Hashimoto S., Suzanne W. J., et al. Pediatric long-COVID: An overlooked phenomenon? Pediatr. Pulmonol. 2021;56:2495&#x2013;2502. doi: 10.1002/ppul.25521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25521</ArticleId><ArticleId IdType="pmc">PMC8242715</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110:914&#x2013;921. doi: 10.1111/apa.15673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., Gaini S., Str&#xf8;m M., Marin Str&#xf8;m M., Weihe P. Long COVID in the Faroe Islands&#x2014;A longitudinal study among non-hospitalized patients. Clin. Infect. Dis. 2020;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carfi A., Valentini P. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T., Ulyte A., Puhan M.A., Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021;326:869&#x2013;871. doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadarangani M., Marchant A., Kollmann T.R. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat. Rev. Immunol. 2021;21:475&#x2013;484. doi: 10.1038/s41577-021-00578-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00578-z</ArticleId><ArticleId IdType="pmc">PMC8246128</ArticleId><ArticleId IdType="pubmed">34211186</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Capdevila Pujol J., Klaser K., Antonelli M., LCanas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell E. Unpacking post-covid symptoms. BMJ. 2021;373:n1173. doi: 10.1136/bmj.n1173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1173</ArticleId><ArticleId IdType="pubmed">34011496</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: A population-based cohort study. Thorax. 2021;76:405&#x2013;407. doi: 10.1136/thoraxjnl-2020-216377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D., Seco-Calvo J., Fernandez-Lazaro C.I., S&#xe1;nchez-Serrano N. XVII Scientific Meeting: Science, technology and innovation at the service of the pandemic response plan in Colombia. The puzzling new condition associated with SARS-CoV-2 infection: Long COVID. Oral Commun. Biomed. 2021;41:79.</Citation></Reference><Reference><Citation>Poyraz B.&#xc7;., Poyraz C.A., Olgun Y., G&#xfc;rel &#xd6;., Alkan S., &#xd6;zdemir Y.E., Balkan I.I., Karaali R. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res. 2021;295:113604. doi: 10.1016/j.psychres.2020.113604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113604</ArticleId><ArticleId IdType="pmc">PMC7695976</ArticleId><ArticleId IdType="pubmed">33296818</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazato Y., Morioka S., Tsuzuki S., Akashi M., Osanai Y., Tanaka K., Terada M., Suzuki M., Kutsuna S., Saito S., et al. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open Forum Infect. Dis. 2020;7:ofaa507. doi: 10.1093/ofid/ofaa507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa507</ArticleId><ArticleId IdType="pmc">PMC7665672</ArticleId><ArticleId IdType="pubmed">33230486</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Margalit I., Yahav D., Runold M., Bruchfeld J. Long COVID-19&#x2014;It&#x2019;s not over until? Clini. Microbiol. Infect. 2021;27:506&#x2013;508. doi: 10.1016/j.cmi.2020.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7832095</ArticleId><ArticleId IdType="pubmed">33316400</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Borst B., Peters J.B., Brink M., Schoon Y., Bleeker-Rovers C.P., Schers H., van Hees H.W.H., van Helvoort H., van den Boogaard M., van der Hoeven H., et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin. Infect. Dis. 2020;73:e1089&#x2013;e1098. doi: 10.1093/cid/ciaa1750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M., Cari&#xf1;ena A., Moreno E., Rodr&#xed;guez N., Dom&#xed;nguez M.J., Casal A., Vanessa Riveiro V., Diaz-Vieito M., Vald&#xe9;s L., &#xc1;lvarez J., et al. Post-COVID-19 functional status six-months after hospitalization. J. Infect. 2021;82:e31&#x2013;e33. doi: 10.1016/j.jinf.2020.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanish Society of General and Family Physicians (SEMG)  Survey of Symptoms and Disability Produced by the Same, in Those Affected by Persistent COVID. 2021.  [(accessed on 1 September 2021)]. pp. 1&#x2013;33. Available online:  https://www.semg.es.</Citation></Reference><Reference><Citation>Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 1982;36:936&#x2013;942. doi: 10.1093/ajcn/36.5.936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/36.5.936</ArticleId><ArticleId IdType="pubmed">7137077</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilagut G., Ferrer M., Rajmil L., Rebollo P., Permanyer-Miralda G., Quintana J.M., Rosal&#xed;a Santeda R., Valderasa J.M., Riberad A., Domingo-Salvanya A., et al. The Spanish SF-36 Health Questionnaire: A decade of experience and new developments by researchers of the Red-IRYSS. Gac. Sanit. 2005;19:135&#x2013;150. doi: 10.1157/13074369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1157/13074369</ArticleId><ArticleId IdType="pubmed">15860162</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x201c;The long tail of Covid-19&#x201d;&#x2014;The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2020;9:1349. doi: 10.12688/f1000research.27287.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Cojocarum M., Cojocarum I.M., Silos I., Vrabie C.D. Manifestations of Systemic Lupus Erythematosus. M&#xe6;dica. 2011;6:330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391953</ArticleId><ArticleId IdType="pubmed">22879850</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Liu S.-M., Yu X.-H., Tang S.-L., Tang C.-K. Coronavirus disease 2019 (COVID-19): Current status and future perspectives. Int. J. Antimicrob. Agents. 2020;55:105951. doi: 10.1016/j.ijantimicag.2020.105951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105951</ArticleId><ArticleId IdType="pmc">PMC7139247</ArticleId><ArticleId IdType="pubmed">32234466</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanish Society of General and Family Physicians (SEMG)  Clinical Guideline for the Care of the Persistent Long COVID/COVID Patient. 2021.  [(accessed on 1 September 2021)].  Available online:  https://www.semg.es/index.php/consensos-guias-y-protocolos/363-guia-clinica-para-la-atencion-al-paciente-long-covid-covid-persistente.</Citation></Reference><Reference><Citation>Muench P., Jochum S., Wenderoth V., Ofenloch-Haehnle B., Hombach M., Strobl M., Henrik Sadlowski H., Sachse C., Torriani G., Isabella Eckerle I., et al. Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2. J. Clin. Microbiol. 2020;58:1694&#x2013;1714. doi: 10.1128/JCM.01694-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01694-20</ArticleId><ArticleId IdType="pmc">PMC7512151</ArticleId><ArticleId IdType="pubmed">32747400</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun J., Loyal L., Frentsch M., Wendisch D., Georg P., Kurth F., Hippenstiel S., Dingeldey M., Kruse B., Fauchere F., et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587:270&#x2013;274. doi: 10.1038/s41586-020-2598-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2598-9</ArticleId><ArticleId IdType="pubmed">32726801</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug (FDA)  Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test. FDA.  [(accessed on 1 September 2021)];2021  Available online:  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-adaptive-biotechnologies-t-detect-covid-test.</Citation></Reference><Reference><Citation>Spanish Society of General and Family Physicians (SEMG)  Basic Care Kit for Patients with Persistent COVID-19 Disease. 2021.  [(accessed on 1 September 2021)].  Available online:  https://semst.org/kit-de-atencion-basica-al-paciente-con-enfermedad-covid-19-persistente/</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D., Gonz&#xe1;lez-Bernal J.J., S&#xe1;nchez-Serrano N., Navascu&#xe9;s L.J., Ascaso-del-R&#xed;o A., Mielgo-Ayuso J. Physical Exercise as a Multimodal Tool for COVID-19: Could It Be Used as a Preventive Strategy? Int. J. Environ. Res. Public Health. 2020;17:8496. doi: 10.3390/ijerph17228496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17228496</ArticleId><ArticleId IdType="pmc">PMC7697788</ArticleId><ArticleId IdType="pubmed">33212762</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>